Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

400
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
400
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

432
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
432
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

337
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
337
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

469
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
469
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

534
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

541
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
541

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mitral Transcatheter Edge-to-Edge Repair in Non-Surgical Candidates with Hypertrophic Obstructive Cardiomyopathy: Clip It, or Ablate It?

Journal of cardiovascular development and disease·2026
Same author

Kounis Syndrome Features in Special Populations.

Medical sciences (Basel, Switzerland)·2026
Same author

GLP-1 Receptor Agonists in Acute Ischemic Stroke and Secondary Stroke Prevention: A Narrative Review of Preclinical and Clinical Evidence.

Journal of central nervous system disease·2026
Same author

Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002-2022).

International journal of obesity (2005)·2026
Same author

Machine Learning-driven Prioritisation of Lipoprotein(a) Testing: Model Development and Validation.

European journal of preventive cardiology·2026
Same author

Efficacy of Obicetrapib Across the Spectrum of Background Lipid-Lowering Therapies: Pooled Analyses of the BROADWAY and BROOKLYN Randomized Trials.

European journal of preventive cardiology·2025

相关实验视频

Updated: Feb 27, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

预防心脏切除术后综合征:目前的证据和未来的方向

Christos E Ballas1, Thomas Theologou1, Evangelia Samara2

  • 1Department of Cardiac Surgery, University Hospital of Ioannina, 45500 Ioannina, Greece.

Journal of cardiovascular development and disease
|February 26, 2026
PubMed
概括

术后心脏切除综合征 (PPS) 的预防可以通过胆固醇,新的手术技术和基于生物标志物的风险分层来优化. 这些策略可以减少心脏手术后的炎症,改善患者的治疗结果,降低住院率.

关键词:
生物标志物 生物标志物心脏外科手术的心脏手术科尔奇辛 (Colchicine) 是一种可怕的药物.周心脏的闭合.术后心脏切除综合征是什么?预防 预防 预防

更多相关视频

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

7.0K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K

相关实验视频

Last Updated: Feb 27, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
07:02

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

7.0K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K

科学领域:

  • 心脏病学 心脏病学
  • 胸部外科手术 胸部外科手术
  • 炎症研究 炎症研究

背景情况:

  • 术后心脏切除综合征 (PPS) 是心脏手术后常见的炎症并发症,导致显著的发病率和死亡率.
  • 目前对PPS的预防策略往往是经验性的,缺乏标准化和基于机制的方法.

研究的目的:

  • 批判性地综合现有的PPS预防策略,包括药理学,手术和基于生物标志物的方法.
  • 解决当前PPS预防方面的缺陷,并探索新兴的风险分层工具.

主要方法:

  • 随机对照试验,元分析,队列研究和机制研究的文献综述.
  • 对药理干预,手术方式和基于生物标志物的预防策略的评估.

主要成果:

  • 胆固醇是最有证据的药理干预措施,始终降低了PPS发病率.
  • 术术技术,如心周关闭和后心周切除术,可以减少并发症,而不会影响血液动力学.
  • 生物标志物 (中性粒细胞与淋巴细胞的比率,CRP,细胞因子) 有助于识别高风险患者进行个性化预防.

结论:

  • 基于证据的药理学预防 (colchicine),创新的手术技术和生物标志物引导的风险分层的结合提供了一条减少PPS发病率和负担的途径.
  • 个性化预防策略正在成为当代心脏外科手术中PPS管理的关键.